Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001127602-24-023163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-29 | 2024-08-28 | TMO | Williamson Stephen | SVP, CFO | F - Tax | $613.14 | -541.03 | 18.5K | -3% | -$331.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | F | D | 214.67 | $613.14 | 18,778.17 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-28 | F | D | 183.73 | $613.14 | 18,594.44 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-28 | F | D | 142.63 | $613.14 | 18,451.81 | D | — | — |